Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michinori Sakai is active.

Publication


Featured researches published by Michinori Sakai.


Journal of Pharmacy and Pharmacology | 1998

Biopharmaceutics: Cytotoxicity of Absorption Enhancers in Caco‐2 Cell Monolayers

Michinori Sakai; Teruko Imai; Hiroshi Ohtake; Masaki Otagiri

This study was performed to evaluate the utility of absorption enhancers with reference to mucosal cell cytotoxicity. Overall assessment of the damage to plasma, lysosomal and nuclear membranes by three absorption enhancers, sodium deoxycholate, sodium caprate and dipotassium glycyrrhizinate, was performed on Caco‐2 cell monolayers.


Life Sciences | 1998

Effects of absorption enhancers on cytoskeletal actin filaments in Caco-2 cell monolayers

Michinori Sakai; Teruko Imai; Hiroshi Ohtake; Hidekazu Azuma; Masaki Otagiri

Histomorphological changes of actin filaments, intracellular levels of calcium ion, and amount of released lactate dehydrogenase (LDH) were examined, in order to elucidate the mechanism of action of three absorption enhancers, i.e., sodium caprate (Cap-Na), sodium deoxycholate (Deo-Na), and dipotassium glycyrrhizinate (Grz-K), using Caco-2 cell monolayers. The structure of actin filaments in microvilli was slightly modified by 0.5 %(w/v) Grz-K and was significantly changed by 0.2 %(w/v) Cap-Na, 0.05 %(w/v) Deo-Na, and 0.0015 %(w/v) ionomycin. All of the enhancers, except Grz-K, induced significantly histomorphological changes in the actin filaments on the middle depth and basal side of the cells. Furthermore, the altered structure of the actin filaments in the monolayers was restored after removal of the Cap-Na, Grz-K and ionomycin, but not Deo-Na. Intracellular levels of calcium ion increased in the following order: ionomycin = Cap-Na > Deo-Na. However, the intracellular calcium ion levels decreased by treatment with Grz-K. The changes in transepithelial electric resistance (TEER) at the initial stage of treatment with all enhancers correlated with intracellular calcium ion levels. These results suggest that one of the mechanisms by which these agents exert absorption-enhancing activity involves structural alterations in the cytoskeletal actin filaments which are provoked by changes in intracellular calcium ion levels. Only the monolayers which were treated with 0.05 %(w/v) Deo-Na released a significant amount of LDH and irreversibly altered the structure of actin filaments, thus indicating that Deo-Na might affect the actin filaments not only by increasing intracellular calcium ion level but also by other, presently unknown factors.


Pharmaceutical Research | 1999

IN VITRO AND IN VIVO EVALUATION OF THE ENHANCING ACTIVITY OF GLYCYRRHIZIN ON THE INTESTINAL ABSORPTION OF DRUGS

Teruko Imai; Michinori Sakai; Hiroshi Ohtake; Hidekazu Azuma; Masaki Otagiri

AbstractPurpose. The enhancing activity of dipotassium glycyrrhizinate (Grz) on the intestinal absorption of drugs has been demonstrated in an in vitro study using Caco-2 cell monolayers and in an invivo absorption study in rats. Methods. The hydrolysis of Grz by luminal content and mucosa of the rat colon was investigated. The absorption-enhancing activity of Grz and its hydrolysates was estimated by changes in transepithelial electrical resistance (TEER) and the permeation of sodium fluorescein (Flu-Na) in Caco-2 cell monolayers. It was further evaluated through the absorption of salmon calcitonin (sCT) in the rat colon. Results. Grz was not hydrolyzed to glycyrrhetinylmonoglucuronide (GrMG) and glycyrrhetinic acid (GA) by colonic mucosa, but, rather by the β-glucuronidase in colonic flora. The hydrolysis of Grz to GrMG was extremely slow and the GrMG produced was rapidly regenerated to GA. Grz and GrMG had no effect on TEER nor on the permeability of Flu-Na across Caco-2 cell monolayers. On the other hand, GA decreased TEER and increased the permeability of Flu-Na in a dose-dependent manner. However, Grz and GrMG enhanced the plasma calcium-lowering effect of sCT after administration in the rat colon. The coadministration of sCT and GA in the rat colon induced the strongest plasma calcium-lowering effect and the highest plasma concentration of sCT. Conclusions. The in vivo enhancing-activity of Grz in the absorption of drugs is dependent on GA, a hydrolysis product of Grz resulting from the action of β-glucuronidase in intestinal flora.


Journal of Pharmacy and Pharmacology | 1999

Simultaneous Use of Sodium Deoxycholate and Dipotassium Glycyrrhizinate Enhances the Cellular Transport of Poorly Absorbed Compounds Across Caco‐2 Cell Monolayers

Michinori Sakai; Teruko Imai; Hiroshi Ohtake; Hidekazu Azuma; Masaki Otagiri

The absorption‐enhancing effect of a combination of sodium deoxycholate and dipotassium glycyrrhizinate in Caco‐2 cell monolayers has been compared with that of the enhancers when used alone, and the mechanism of the enhancement was partially elucidated.


Neuroscience Letters | 1998

Anti-emetic effects of a novel NK-1 receptor antagonist HSP-117 in ferrets

Ryo Saito; Yumiko Suehiro; Hideto Ariumi; Keisuke Migita; Nobuaki Hori; Terusi Hashiguchi; Michinori Sakai; Masakazu Saeki; Yukio Takano; Hiro-o Kamiya

We have developed a non-peptide compound, HSP-117, antagonist of the tachykinin NK-1 receptor. Binding of 3H-substance P (SP) to the membranes of IM-9 cells was inhibited by the antagonists HSP-117 and CP-99,994, the inhibitory activity of HSP-117 being about 50-fold that of CP-99,994. The SP-induced firing responses of single neuron activity in slices of the nucleus tractus solitarius of ferrets were inhibited by 10 microM HSP-117. Intracerebroventricular injection of HSP-117 significantly inhibited retching and vomiting induced by copper sulphate and morphine and the inhibitory effect of HSP-117 on emesis was greater than that of CP-99,994. These results indicate that (1) HSP-117 is a potent anti-emetic agent, blocking NK-1 receptors in the nucleus tractus solitarius and (2) NK-1 receptors in the nucleus tractus solitarius play an important role in emesis induced by broad-spectrum emetic stimuli.


Journal of Pharmaceutical Sciences | 1997

Effects of Absorption Enhancers on the Transport of Model Compounds in Caco-2 Cell Monolayers: Assessment by Confocal Laser Scanning Microscopy

Michinori Sakai; Teruko Imai; Hiroshi Ohtake; Hidekazu Azuma; Masaki Otagiri


Japanese Journal of Pharmacology | 2001

Effects of HSP-117, a Novel Tachykinin NK1-Receptor Antagonist, on Cisplatin-Induced Pica as a New Evaluation of Delayed Emesis in Rats

Masakazu Saeki; Michinori Sakai; Ryo Saito; Hisahiko Kubota; Hideto Ariumi; Yukio Takano; Atsushi Yamatodani; Hiro-o Kamiya


Archive | 1987

Azacycloalkane derivatives, absorption promoters containing the derivatives as the effective ingredient and external preparations containing the absorption promoters

Masayoshi Tsuji; Hisataka Inoue; Terumi Hachiya; Mikio Nakashima; Masaru Saita; Yuji Shimozono; Akira Nakagawa; Michinori Sakai


International Journal of Pharmaceutics | 2005

Absorption-enhancing effect of glycyrrhizin induced in the presence of capric acid

Teruko Imai; Michinori Sakai; Hiroshi Ohtake; Hidekazu Azuma; Masaki Otagiri


Journal of Physical Chemistry B | 2007

Reaction Dynamics of Excited Ketoprofen with Triethylamine

Hiroyuki Suzuki; Tadashi Suzuki; Teijiro Ichimura; Koichi Ikesue; Michinori Sakai

Collaboration


Dive into the Michinori Sakai's collaboration.

Top Co-Authors

Avatar

Koichi Ikesue

Hisamitsu Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Ohtake

Hisamitsu Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kazuhisa Yoshitake

Hisamitsu Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kenji Atarashi

Hisamitsu Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Masaki Otagiri

Hisamitsu Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Teruko Imai

Hisamitsu Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kiyomi Tsuruda

Hisamitsu Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Tetsuji Kuwahara

Hisamitsu Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Yoshiaki Hashimoto

Hisamitsu Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge